Etomidate in intensive care unit: A molecule in deferment?;Étomidate au bloc et en réanimation : une molécule en sursis ?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 27, Issue 11, 2008, Pages 887-889

  Mezzour, A ^a   Lehot, J J ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

Cortisol; Etomidate; ICU; Sedation

Indexed keywords

CATECHOLAMINE; ETOMIDATE; HYDROCORTISONE; KETAMINE; THIOPENTAL; HYPNOTIC SEDATIVE AGENT;

DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; DRUG UTILIZATION; EDITORIAL; INTENSIVE CARE UNIT; SEDATION; HUMAN; INTENSIVE CARE;

ETOMIDATE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; INTENSIVE CARE UNITS;

EID: 56949084985     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2008.10.011     Document Type: Editorial

References (18)

1. Sprung J., Ogletree-Hughes M.L., and Moravec S. The effects of etomidate on the contractility of failing and nonfailing human heart muscle. Anesth Analg 91 (2000) 68-75
2. Gooding J.M., Weng J.T., Smith R.A., Berninger G.T., and Kirby R.R. Cardiovascular and pulmonary responses following etomidate induction of anesthesia in patients with demonstrated cardiac disease. Anesth Analg 58 (1979) 40-41
3. Wagner R.L., White P.F., Kan P.B., Rosenthal M.H., and Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 310 (1984) 1415-1421
4. Morris C., and McAllister C. Etomidate for emergency anaesthesia: mad, bad and dangerous to know?. Anaesthesia 60 (2005) 737-740
5. Annane D. ICU physicians should abandon the use of etomidate!. Intensive Care Med 31 (2005) 325-326
6. Jackson Jr. W.L. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock? A critical appraisal. Chest 127 (2005) 1031-1038
7. Zurich AM SH, Koehler LS. Magnitude and time course of perioperative adrenal suppression with single dose etomidate in male cardiac surgical patients [abstract]. Anesthesiology 1986;65:A248.
8. Absalom A., Pledger D., and Kong A. Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia 54 (1999) 861-867
9. Schenarts C.L., Burton J.H., and Riker R.R. Adrenocortical dysfunction following etomidate induction in emergency department patients. Acad Emerg Med 8 (2001) 1-7
10. Annane D., Sebille V., Troche G., Raphael J.C., Gajdos P., and Bellissant E. A three-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283 (2000) 1038-1045
11. Brussel T., Theissen J.L., Vigfusson G., Lunkenheimer P.P., Van Aken H., and Lawin P. Hemodynamic and cardiodynamic effects of propofol and etomidate: negative inotropic properties of propofol. Anesth Analg 69 (1989) 35-40
12. Stowe D.F., Bosnjak Z.J., and Kampine J.P. Comparison of etomidate, ketamine, midazolam, propofol, and thiopental on function and metabolism of isolated hearts. Anesth Analg 74 (1992) 547-558
13. Warden J.C., and Pickford D.R. Fatal cardiovascular collapse following propofol induction in high-risk patients and dilemmas in the selection of a short-acting induction agent. Anaesth Intensive Care 23 (1995) 485-487
14. Kertai M.D., Bountioukos M., Boersma E., Bax J.J., Thomson I.R., Sozzi F., et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med 116 (2004) 8-13
15. Bendel S., Ruokonen E., Polonen P., and Uusaro A. Propofol causes more hypotension than etomidate in patients with severe aortic stenosis: a double-blind, randomized study comparing propofol and etomidate. Acta Anaesthesiol Scand 51 (2007) 284-289
16. Chauvin M. Thiopental. Encycl Med Chir (Elsevier, Paris). Anesthésie-Réanimation. (1989) 10 p
17. Adams H.A. S-(+)-ketamine. Circulatory interactions during total intravenous anesthesia and analgesia sedation. Anaesthesist 46 (1997) 1081-1087
18. Payen J.F., Vinclair M., Broux C., Faure P., and Chabre O. Faut-il encore utiliser l'étomidate ?. Ann Fr Anesth Reanim 27 (2008) 915-919